Auerbach Alan H.'s Insider Trades & SAST Disclosures
Auerbach Alan H.'s most recent trade in Puma Biotechnology Inc was a trade of 274,622 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 7, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Auerbach Alan H..To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Puma Biotechnology Inc | Alan H. Auerbach | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2025 | 274,622 | 274,622 | - | - | Stock Option (Right to Buy) | |
| Puma Biotechnology Inc | Alan H. Auerbach | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2025 | 198,399 | 7,228,073 (18%) | 0% | 0 | Common Stock | |
| Puma Biotechnology Inc | Alan H. Auerbach | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 3.15 per share. | 02 Jan 2025 | 33,841 | 7,029,674 (17%) | 0% | 3.2 | 106,657 | Common Stock |
| Puma Biotechnology Inc | Alan H. Auerbach | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 3.70 per share. | 17 Jul 2024 | 21,920 | 7,063,515 (17%) | 0% | 3.7 | 81,128 | Common Stock |
| Puma Biotechnology Inc | Alan H. Auerbach | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 3.27 per share. | 02 Jul 2024 | 18,885 | 7,085,435 (18%) | 0% | 3.3 | 61,726 | Common Stock |
| Puma Biotechnology Inc | Alan H. Auerbach | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 9,047 | 9,047 | - | - | Stock Option (Right to Buy) | |
| Puma Biotechnology Inc | Alan H. Auerbach | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 6,577 | 7,104,320 (18%) | 0% | 0 | Common Stock | |
| Puma Biotechnology Inc | H. Auerbach Alan | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 222,573 | 222,573 | - | - | Stock Option (Right to Buy) | |
| Puma Biotechnology Inc | Auerbach Alan H. | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 160,796 | 7,097,743 (18%) | 0% | 0 | Common Stock | |
| Puma Biotechnology Inc | Alan Auerbach H. | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 4.49 per share. | 03 Jan 2024 | 41,396 | 6,936,947 (17%) | 0% | 4.5 | 185,698 | Common Stock |
| Puma Biotechnology Inc | Alan H. Auerbach | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 3.31 per share. | 03 Jul 2023 | 60,698 | 6,978,343 (17%) | 0% | 3.3 | 200,983 | Common Stock |
| Puma Biotechnology Inc | Alan H. Auerbach | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2023 | 258,924 | 258,924 | - | - | Stock Option (Right to Buy) | |
| Puma Biotechnology Inc | Alan H. Auerbach | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2023 | 186,403 | 7,039,041 (17%) | 0% | 0 | Common Stock | |
| Puma Biotechnology Inc | Alan H. Auerbach | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 4.18 per share. | 03 Jan 2023 | 27,241 | 6,852,638 (17%) | 0% | 4.2 | 113,810 | Common Stock |
| Puma Biotechnology Inc | Alan H. Auerbach | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 4.40 per share. | 12 Dec 2022 | 568,181 | 6,879,879 (17%) | 1% | 4.4 | 2,499,996 | Common Stock |
| Puma Biotechnology Inc | Alan H. Auerbach | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 4.50 per share. | 02 Dec 2022 | 1,251 | 6,311,698 (16%) | 0% | 4.5 | 5,627 | Common Stock |
| Puma Biotechnology Inc | Alan H. Auerbach | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.25 per share. | 02 Nov 2022 | 1,242 | 6,312,949 (16%) | 0% | 2.3 | 2,795 | Common Stock |
| Puma Biotechnology Inc | Alan H. Auerbach | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.34 per share. | 03 Oct 2022 | 1,260 | 6,314,191 (16%) | 0% | 2.3 | 2,943 | Common Stock |
| Puma Biotechnology Inc | Alan H. Auerbach | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.59 per share. | 02 Sep 2022 | 1,254 | 6,315,451 (16%) | 0% | 2.6 | 3,247 | Common Stock |
| Puma Biotechnology Inc | Alan H. Auerbach | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.89 per share. | 02 Aug 2022 | 1,247 | 6,316,705 (16%) | 0% | 2.9 | 3,604 | Common Stock |
| Puma Biotechnology Inc | Alan H. Auerbach | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.63 per share. | 05 Jul 2022 | 26,140 | 6,317,952 (16%) | 0% | 2.6 | 68,787 | Common Stock |
| Puma Biotechnology Inc | Alan H. Auerbach | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 1.94 per share. | 02 Jun 2022 | 1,200 | 6,344,092 (16%) | 0% | 1.9 | 2,333 | Common Stock |
| Puma Biotechnology Inc | Alan H. Auerbach | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.32 per share. | 03 May 2022 | 1,263 | 6,345,292 (16%) | 0% | 2.3 | 2,930 | Common Stock |
| Puma Biotechnology Inc | Alan H. Auerbach | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 3.08 per share. | 04 Apr 2022 | 1,198 | 6,346,555 (16%) | 0% | 3.1 | 3,687 | Common Stock |
| Sutro Biopharma Inc | Alan H. Auerbach | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 52,000 | 52,000 | - | - | Stock Option (right to buy Common Stock) | |
| Sutro Biopharma Inc | Alan H. Auerbach | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 39,000 | 39,000 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Alan H. Auerbach | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2022 | 12,500 | 37,500 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Alan H. Auerbach | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2022 | 12,500 | 42,091 (0%) | 0% | - | Common Stock | |
| Sutro Biopharma Inc | Alan H. Auerbach | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.17 per share. | 04 Mar 2022 | 4,355 | 37,736 (0%) | 0% | 8.2 | 35,580 | Common Stock |
| Puma Biotechnology Inc | Alan H. Auerbach | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 2.79 per share. | 03 Mar 2022 | 1,792,114 | 6,347,753 (16%) | 4% | 2.8 | 4,999,998 | Common Stock |
| Puma Biotechnology Inc | Alan H. Auerbach | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 241,176 | 241,176 | - | - | Stock Option (Right to Buy) | |
| Puma Biotechnology Inc | Alan H. Auerbach | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 168,824 | 4,555,639 (11%) | 0% | 0 | Common Stock | |
| Puma Biotechnology Inc | Alan H. Auerbach | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.26 per share. | 02 Mar 2022 | 1,294 | 4,386,815 (11%) | 0% | 2.3 | 2,919 | Common Stock |
| Puma Biotechnology Inc | Alan H. Auerbach | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.46 per share. | 02 Feb 2022 | 1,316 | 4,388,109 (11%) | 0% | 2.5 | 3,239 | Common Stock |
| Sutro Biopharma Inc | Alan H. Auerbach | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2022 | 5,250 | 10,500 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Alan H. Auerbach | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2022 | 5,250 | 31,742 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | Alan H. Auerbach | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.39 per share. | 29 Jan 2022 | 2,151 | 29,591 (0%) | 0% | 10.4 | 22,349 | Common Stock |
| Puma Biotechnology Inc | Alan H. Auerbach | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 3.19 per share. | 03 Jan 2022 | 22,875 | 4,389,425 (11%) | 0% | 3.2 | 72,923 | Common Stock |
| Puma Biotechnology Inc | Alan H. Auerbach | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.90 per share. | 02 Dec 2021 | 1,837 | 4,412,300 (11%) | 0% | 2.9 | 5,327 | Common Stock |
| Puma Biotechnology Inc | Alan H. Auerbach | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 5.63 per share. | 02 Nov 2021 | 1,795 | 4,414,137 (11%) | 0% | 5.6 | 10,112 | Common Stock |
| Puma Biotechnology Inc | Alan H. Auerbach | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 6.15 per share. | 04 Oct 2021 | 1,858 | 4,415,932 (11%) | 0% | 6.2 | 11,433 | Common Stock |
| Sutro Biopharma Inc | Alan H. Auerbach | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Sep 2021 | 8,609 | 29,468 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | Alan H. Auerbach | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Sep 2021 | 8,609 | 0 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Alan H. Auerbach | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.23 per share. | 24 Sep 2021 | 2,976 | 26,492 (0%) | 0% | 19.2 | 57,228 | Common Stock |
| Puma Biotechnology Inc | Alan H. Auerbach | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.53 per share. | 02 Aug 2021 | 1,764 | 4,419,554 (11%) | 0% | 7.5 | 13,286 | COMMON STOCK |
| Puma Biotechnology Inc | Alan H. Auerbach | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 8.84 per share. | 02 Jul 2021 | 5,332 | 4,421,318 (11%) | 0% | 8.8 | 47,121 | COMMON STOCK |
| Puma Biotechnology Inc | Alan H. Auerbach | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 10.74 per share. | 02 Jun 2021 | 1,757 | 4,426,650 (11%) | 0% | 10.7 | 18,877 | COMMON STOCK |
| Puma Biotechnology Inc | Alan H. Auerbach | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.01 per share. | 03 May 2021 | 1,758 | 4,428,407 (11%) | 0% | 9.0 | 15,847 | COMMON STOCK |
| Puma Biotechnology Inc | Alan H. Auerbach | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.80 per share. | 05 Apr 2021 | 1,584 | 4,430,165 (11%) | 0% | 9.8 | 15,528 | COMMON STOCK |
| Sutro Biopharma Inc | Alan H. Auerbach | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2021 | 60,000 | 60,000 | - | - | Stock Option (right to buy Common Stock) | |
| Sutro Biopharma Inc | Alan H. Auerbach | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2021 | 50,000 | 50,000 | - | - | Restricted Stock Unit (RSU) | |
| Puma Biotechnology Inc | Alan H. Auerbach | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 10.14 per share. | 02 Mar 2021 | 1,238 | 4,431,749 (11%) | 0% | 10.1 | 12,556 | COMMON STOCK |
| Puma Biotechnology Inc | Alan H. Auerbach | Director, PRESIDENT AND CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 210,944 | 210,944 | - | - | STOCK OPTION (RIGHT TO BUY) | |
| Puma Biotechnology Inc | Alan H. Auerbach | Director, PRESIDENT AND CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 149,951 | 4,432,987 (11%) | 0% | 0 | COMMON STOCK | |
| Puma Biotechnology Inc | Alan H. Auerbach | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 12.22 per share. | 02 Feb 2021 | 1,222 | 4,283,036 (10%) | 0% | 12.2 | 14,931 | COMMON STOCK |
| Sutro Biopharma Inc | Alan H. Auerbach | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2021 | 5,250 | 15,750 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Alan H. Auerbach | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2021 | 5,250 | 22,966 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | Alan H. Auerbach | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.15 per share. | 29 Jan 2021 | 2,107 | 20,859 (0%) | 0% | 22.1 | 46,670 | Common Stock |
| Puma Biotechnology Inc | Alan H. Auerbach | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 10.22 per share. | 04 Jan 2021 | 18,235 | 4,284,258 (10%) | 0% | 10.2 | 186,380 | COMMON STOCK |
| Puma Biotechnology Inc | Alan H. Auerbach | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 11.66 per share. | 02 Dec 2020 | 355 | 4,302,493 (10%) | 0% | 11.7 | 4,138 | COMMON STOCK |
| Puma Biotechnology Inc | Alan H. Auerbach | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.81 per share. | 02 Nov 2020 | 371 | 4,302,848 (10%) | 0% | 7.8 | 2,899 | COMMON STOCK |
| Puma Biotechnology Inc | Alan H. Auerbach | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 10.13 per share. | 02 Oct 2020 | 350 | 4,303,219 (10%) | 0% | 10.1 | 3,545 | COMMON STOCK |
| Sutro Biopharma Inc | Alan H. Auerbach | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Sep 2020 | 8,609 | 20,692 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | Alan H. Auerbach | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Sep 2020 | 8,609 | 8,609 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Alan H. Auerbach | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.30 per share. | 25 Sep 2020 | 2,976 | 17,716 (0%) | 0% | 10.3 | 30,653 | Common Stock |
| Puma Biotechnology Inc | Alan H. Auerbach | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.78 per share. | 02 Sep 2020 | 347 | 4,303,569 (10%) | 0% | 9.8 | 3,393 | COMMON STOCK |
| Puma Biotechnology Inc | Alan H. Auerbach | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 10.79 per share. | 03 Aug 2020 | 330 | 4,303,916 (10%) | 0% | 10.8 | 3,561 | COMMON STOCK |
| Puma Biotechnology Inc | Alan H. Auerbach | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 10.66 per share. | 02 Jul 2020 | 2,607 | 4,304,246 (10%) | 0% | 10.7 | 27,803 | COMMON STOCK |
| Puma Biotechnology Inc | Alan H. Auerbach | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 10.71 per share. | 02 Jun 2020 | 242 | 4,306,853 (10%) | 0% | 10.7 | 2,592 | COMMON STOCK |
| Puma Biotechnology Inc | Alan H. Auerbach | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 10.70 per share. | 02 Jun 2020 | 100 | 4,307,095 (10%) | 0% | 10.7 | 1,070 | COMMON STOCK |
| Sutro Biopharma Inc | Alan H. Auerbach | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 7.75 per share. | 14 May 2020 | 6,451 | 12,083 (0%) | 0% | 7.7 | 49,995 | Common Stock |
| Puma Biotechnology Inc | Alan H. Auerbach | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.70 per share. | 04 May 2020 | 339 | 4,307,195 (10%) | 0% | 9.7 | 3,289 | COMMON STOCK |
| Puma Biotechnology Inc | Alan H. Auerbach | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.39 per share. | 02 Apr 2020 | 347 | 4,307,534 (10%) | 0% | 7.4 | 2,563 | COMMON STOCK |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges